Age (years) | 59.7 ± 12.6 |
Sex (% male) | 58.3 |
Duration of diabetes (years) | 13.2 ± 10.2 |
BMI (kg/m2) | 26.1 ± 11.4 |
SBP (mmHg) | 129.7 ± 20.5 |
DBP (mmHg) | 75.5 ± 12.7 |
FPG (mmol/l) | 9.0 ± 3.2 |
HbA1c (%) | 9.1 ± 2.1 |
TC (mmol/l) | 5.21 ± 1.30 |
TG (mmol/l) | 1.91 ± 1.50 |
HDL cholesterol (mmol/l) | 1.28 ± 0.38 |
LDL cholesterol (mmol/l) | 3.06 ± 1.05 |
non-HDL cholesterol (mmol/l) | 3.93 ± 1.30 |
hs-CRP (mg/l) | 0.22 ± 0.41 |
mean-CCA-IMT (mm) | 0.97 ± 0.38 |
max-CCA-IMT (mm) | 1.11 ± 0.53 |
baPWV (cm/s) | 1748.4 ± 360.0 |
UAE (mg/day) | 363.1 ± 891.6 |
total leukocyte count (/mm3) | 6258.1 ± 1656.8 |
Monocyte count (/mm3) | 340.5 ± 106.5 |
Neutrophil count (/mm3) | 3587.2 ± 1232.6 |
Lymphocyte count (/mm3) | 2079.5 ± 680.4 |
Eosinophil count (/mm3) | 208.1 ± 145.5 |
Basophil count (/mm3) | 32.2 ± 25.9 |
Current or former smokers (%) | 52.5 |
Hypertension (%) | 61.8 |
Hyperlipidemia (%) | 55.8 |
Diabetic microangiopathy (%) | Â |
 Retinopathy | 56.6 |
 Neuropathy | 49.8 |
 Nephropathy | 47.3 |
Cardiovascular disease (%) | 18.8 |
Diabetes medication (%) | Â |
 Oral hypoglycemic agents | 50.0 |
 Insulin | 28.3 |
 Oral hypoglycemic agents + insulin | 7.6 |
Statins (%) | 22.3 |
ARBs and/or ACEIs (%) | 29.8 |
CCBs (%) | 29.5 |
Ant-platelet agents (%) | 17.1 |